Suivre
Joseph Sparano
Titre
Citée par
Citée par
Année
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
26252015
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 379 (2), 111-121, 2018
20032018
Prospective validation of a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 373 (21), 2005-2014, 2015
14972015
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ...
Journal of clinical oncology 32 (27), 2959, 2014
13542014
Weekly paclitaxel in the adjuvant treatment of breast cancer
JA Sparano, M Wang, S Martino, V Jones, EA Perez, T Saphner, AC Wolff, ...
New England Journal of Medicine 358 (16), 1663-1671, 2008
11622008
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
8872018
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
CA Hudis, WE Barlow, JP Costantino, RJ Gray, KI Pritchard, ...
Journal of Clinical Oncology 25 (15), 2127-2132, 2007
8102007
Case fatality rate of cancer patients with COVID-19 in a New York hospital system
V Mehta, S Goel, R Kabarriti, D Cole, M Goldfinger, A Acuna-Villaorduna, ...
Cancer discovery 10 (7), 935-941, 2020
7852020
Development of the 21-gene assay and its application in clinical practice and clinical trials
JA Sparano, S Paik
Journal of Clinical Oncology 26 (5), 721-728, 2008
6922008
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (6), 311-335, 2017
6652017
Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology …
S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ...
Advances in anatomic pathology 24 (5), 235-251, 2017
5972017
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
LJ Solin, R Gray, FL Baehner, SM Butler, LL Hughes, C Yoshizawa, ...
Journal of the National Cancer Institute 105 (10), 701-710, 2013
5582013
Randomized controlled trial of yoga among a multiethnic sample of breast cancer patients: effects on quality of life
AB Moadel, C Shah, J Wylie-Rosett, MS Harris, SR Patel, CB Hall, ...
Journal of Clinical Oncology 25 (28), 4387-4395, 2007
5172007
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS …
LD Kaplan, JY Lee, RF Ambinder, JA Sparano, E Cesarman, A Chadburn, ...
Blood 106 (5), 1538-1543, 2005
4772005
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
GS Karagiannis, JM Pastoriza, Y Wang, AS Harney, D Entenberg, ...
Science translational medicine 9 (397), eaan0026, 2017
4522017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open …
SA Hurvitz, M Martin, WF Symmans, KH Jung, CS Huang, AM Thompson, ...
The Lancet Oncology 19 (1), 115-126, 2018
4432018
Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer
JA Sparano, RJ Gray, PM Ravdin, DF Makower, KI Pritchard, KS Albain, ...
New England journal of medicine 380 (25), 2395-2405, 2019
4302019
Progress in adjuvant chemotherapy for breast cancer: an overview
J Anampa, D Makower, JA Sparano
BMC medicine 13, 1-13, 2015
4052015
Prognostic utility of the 21-gene assay in hormone receptor–positive operable breast cancer compared with classical clinicopathologic features
LJ Goldstein, R Gray, S Badve, BH Childs, C Yoshizawa, S Rowley, ...
Journal of Clinical Oncology 26 (25), 4063, 2008
3952008
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern …
JA Sparano, P Bernardo, P Stephenson, WJ Gradishar, JN Ingle, S Zucker, ...
Journal of Clinical Oncology 22 (23), 4683-4690, 2004
3272004
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20